Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome
Primary Purpose
Refractory Carpal Tunnel Syndrome, Neurpathic Pain, Neuromodulaton
Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
reduction of pain scores by magnetic energy
Sponsored by
About this trial
This is an interventional treatment trial for Refractory Carpal Tunnel Syndrome focused on measuring Carpal Tunnel Syndrome, Neuropathic Pain, Neuromodulation, PEMF, Magnetic Field Therapy, Magnetotherapy
Eligibility Criteria
Inclusion Criteria: Intractable neuropathic pain in median nerve innervated hand for at least 3 months; Abnormal neurological examination compatible with diagnosis of CTS Exclusion Criteria: Post-surgical failures, Pregnancy, Pts with pacemaker
Sites / Locations
- Michael I. Weintraub MD, PC
Outcomes
Primary Outcome Measures
VAS Pain scores 0-10 (leikert scale)
VAS Sleep interrupption 0-10
Neuropathic Pain scale (NPS)
Secondary Outcome Measures
Neurological Exam
Median nerve distal latencies (CMAP/SNAP)
Hand help Dynamometry and Finger gauge pressures
CPT (Neurometer)
PGIC
Full Information
NCT ID
NCT00277563
First Posted
January 13, 2006
Last Updated
September 20, 2007
Sponsor
Weintraub, Michael I., MD, FACP, FAAN
Collaborators
Dr. Steven P. Cole, PhD. Statistician
1. Study Identification
Unique Protocol Identification Number
NCT00277563
Brief Title
Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome
Official Title
Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome (Cts): A Randomized, Placebo-Controlled Trial With Secondary Bayesian Modification
Study Type
Interventional
2. Study Status
Record Verification Date
September 2007
Overall Recruitment Status
Completed
Study Start Date
June 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
July 2005 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Weintraub, Michael I., MD, FACP, FAAN
Collaborators
Dr. Steven P. Cole, PhD. Statistician
4. Oversight
5. Study Description
Brief Summary
Pulsed electromagnetic fields (PEMF) have been approved by FDA and are utilized currently in treating non-union fractures, neurogenic bladder and musculoskeletal pains. Based on 2 prior pilot studies (open label) demonstrating reduction in neuropathic pain from carpal tunnel syndrome we decided to perform a placebo-controlled trial, randomized for 2 months utilizing a wrist PEMF device attached by Velcro for 4 hours/day.
Detailed Description
INTRODUCTION:
Entrapment of the median nerve at the wrist is the most common cause of sensory and motor disturbance in the hands and can be progressively disabling.1,2 Complex mechanisms of compression and ischemia exist that adversely influence the large A myelinated fibers and small unmyelinated nociceptive C fibers. From a pathophysiological standpoint, neuropathic pain (numbness, tingling and burning, NP) is believed secondary to ectopic firing of nociceptive afferent unmyelinated C-fiber axons that are undergoing degeneration.3 Microneurography has confirmed that dysregulated expression of sodium and calcium channels, which accumulate at site of injury, are responsible for ectopic depolarization.3,4,53,54 When conventional therapy of splinting and pharmacotherapy fail, surgical decompression has been offered for moderate-severe cases. While usually successful, it is associated with significant complications, limitations and costs.5,6,7 Thus, the search for reliable and new therapeutic strategies is appealing.
Substantial evidence exists that time-varying magnetic fields produce biological effects by safely inducing extremely low-frequency (ELF) small electrical eddy currents within the tissues that can depolarize, repolarize and hyperpolarize neurons.8,9,10,11,12
Prior pilot data using static13 and pulsed magnetic fields (PEMF)14,15 directed to the carpal tunnel region significantly reduced NP. Since a new, novel device became commercially available that produced a combination of static and time-varying magnetic fields simultaneously, it was hypothesized that this energy could be directed into the wrists and potentially influence not only NP scores, but also modulate neuronal distal latencies (neurotransmission).
DEVICE:
DESCRIPTION: (FIGURE 1) This patented device (Biaxial Super Mini [Mx2R] by Nikken, Inc.) measures 2" in diameter and 1" in height and is worn with a Velcro strap similar to a wristwatch. It is noiseless and nonthermal. Its main component is a spherical permanent magnet, 1150G, 3/8" in diameter that rotates in two perpendicular directions simultaneously producing biaxial magnetic rotation (MX2R) and oscillating polarities up to 1,200 rpm-20 times per second. It is driven by a 2 V DC micro-motor which is shielded one inch away and produces a negligible back EMF. The device is powered by three ¼ AAA rechargeable NiMH (Nickel Metal Hydride) batteries
Randomized double blind placebo-controlled device with primary parameters of pain and sleep interupption scores, NPS scale and secondary parameters of neurological exam changes, nerve conduction latencies of median nerve, dynamometry, finger gauge pressures, CPT and PGIC were compared at baseline and end of two months. Patients were given a free "active" device gratis at end of study.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Refractory Carpal Tunnel Syndrome, Neurpathic Pain, Neuromodulaton
Keywords
Carpal Tunnel Syndrome, Neuropathic Pain, Neuromodulation, PEMF, Magnetic Field Therapy, Magnetotherapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Double
Allocation
Randomized
Enrollment
50 (false)
8. Arms, Groups, and Interventions
Intervention Type
Device
Intervention Name(s)
reduction of pain scores by magnetic energy
Primary Outcome Measure Information:
Title
VAS Pain scores 0-10 (leikert scale)
Title
VAS Sleep interrupption 0-10
Title
Neuropathic Pain scale (NPS)
Secondary Outcome Measure Information:
Title
Neurological Exam
Title
Median nerve distal latencies (CMAP/SNAP)
Title
Hand help Dynamometry and Finger gauge pressures
Title
CPT (Neurometer)
Title
PGIC
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Intractable neuropathic pain in median nerve innervated hand for at least 3 months;
Abnormal neurological examination compatible with diagnosis of CTS
Exclusion Criteria:
Post-surgical failures,
Pregnancy,
Pts with pacemaker
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Steven P. Cole, PhD
Organizational Affiliation
Statistician
Official's Role
Study Chair
Facility Information:
Facility Name
Michael I. Weintraub MD, PC
City
Briarcliff
State/Province
New York
ZIP/Postal Code
10510
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
18777606
Citation
Weintraub MI, Cole SP. A randomized controlled trial of the effects of a combination of static and dynamic magnetic fields on carpal tunnel syndrome. Pain Med. 2008 Jul-Aug;9(5):493-504. doi: 10.1111/j.1526-4637.2007.00324.x.
Results Reference
derived
Learn more about this trial
Short and Long Term Exposure to Unique, Time-Varying Pulsed Electro-Magnetic Fields in Refractory Carpal Tunnel Syndrome
We'll reach out to this number within 24 hrs